NovoCure initiates newly-diagnosed GBM clinical trial (News-Medical-Net)
Filed in Mesothelioma News on Sep.29, 2009
NovoCure, Ltd., a privately held medical device company focused on developing the Novo-TTF device, a non-invasive portable medical device for the treatment of cancer, announced the completion of a new funding round today. Key investors in this round included Pfizer Inc, Johnson & Johnson Development Corporation and Index Ventures.
